Cargando…

Dexmedetomidine–Ketamine or Dexmedetomidine–Midazolam Nebulised Drug Combination as a Premedicant in Children: A Randomised Clinical Trial

OBJECTIVE: This study was designed to evaluate the clinical efficacy of 2 low-dose nebulised drug combinations of dexmedetomidine–ketamine and dexmedetomidine–midazolam as a premedication in children scheduled for surgery under general anaesthesia. METHODS: Sixty children classified as American Soci...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhiman, Tanvi, Verma, Versha, Verma, Ravinder Kumar, Rana, Shelly, Singh, Jai, Badhan, Isha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Anaesthesiology and Reanimation 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682967/
https://www.ncbi.nlm.nih.gov/pubmed/36301288
http://dx.doi.org/10.5152/TJAR.2022.21298
_version_ 1784834975200182272
author Dhiman, Tanvi
Verma, Versha
Verma, Ravinder Kumar
Rana, Shelly
Singh, Jai
Badhan, Isha
author_facet Dhiman, Tanvi
Verma, Versha
Verma, Ravinder Kumar
Rana, Shelly
Singh, Jai
Badhan, Isha
author_sort Dhiman, Tanvi
collection PubMed
description OBJECTIVE: This study was designed to evaluate the clinical efficacy of 2 low-dose nebulised drug combinations of dexmedetomidine–ketamine and dexmedetomidine–midazolam as a premedication in children scheduled for surgery under general anaesthesia. METHODS: Sixty children classified as American Society of Anesthesiologists physical status I, aged between 3 and 10, listed to undergo elective surgeries under general anaesthesia were enrolled in this prospective, randomised, and double-blind trial. Patients were randomly allocated to receive nebulised premedication approximately 30 minutes before the induction of anaesthesia. Group DK (n = 30) received combined nebulised dexmedetomidine and ketamine (1 μg kg(−1) + 1 mg kg(−1)) and the dexmedetomidine-midazolam (DM) group (n = 30) received combined nebulised dexmedetomidine and midazolam (1 μg kg(−1) + 0.1 mg kg(−1)). All children were anaesthetised with a protocolised anaesthesia technique. The primary end point was the level of sedation when the child was first seen in the operating room 30 minutes after nebulisation. The secondary end points were parental separation and ease of induction, ease of acceptance of IV cannula, mask acceptance, postoperative analgesia, and wake-up behaviour. RESULTS: Studied groups were comparable in demographic data (age, weight, and sex) and duration of anaesthesia. Level of sedation at 30 minutes was significantly greater in the DM group than in the DK group (P  = .013) while the two were comparable in parental separation and ease of induction (P  = .808). Group DK exhibited superior ease of acceptance of IV cannula (P  = .001), mask acceptance score (P  = .001), and postoperative analgesia (P  = .021). Hemodynamic parameters and oxygen saturation remained comparable at all time intervals as also the wake-up behaviour. CONCLUSIONS: The nebulised combination of low-dose ketamine and dexmedetomidine was a superior combination producing acceptable sedation with enhanced ease of IV acceptance, mask acceptance, and postoperative analgesia in children.
format Online
Article
Text
id pubmed-9682967
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Turkish Society of Anaesthesiology and Reanimation
record_format MEDLINE/PubMed
spelling pubmed-96829672022-12-02 Dexmedetomidine–Ketamine or Dexmedetomidine–Midazolam Nebulised Drug Combination as a Premedicant in Children: A Randomised Clinical Trial Dhiman, Tanvi Verma, Versha Verma, Ravinder Kumar Rana, Shelly Singh, Jai Badhan, Isha Turk J Anaesthesiol Reanim Original Article OBJECTIVE: This study was designed to evaluate the clinical efficacy of 2 low-dose nebulised drug combinations of dexmedetomidine–ketamine and dexmedetomidine–midazolam as a premedication in children scheduled for surgery under general anaesthesia. METHODS: Sixty children classified as American Society of Anesthesiologists physical status I, aged between 3 and 10, listed to undergo elective surgeries under general anaesthesia were enrolled in this prospective, randomised, and double-blind trial. Patients were randomly allocated to receive nebulised premedication approximately 30 minutes before the induction of anaesthesia. Group DK (n = 30) received combined nebulised dexmedetomidine and ketamine (1 μg kg(−1) + 1 mg kg(−1)) and the dexmedetomidine-midazolam (DM) group (n = 30) received combined nebulised dexmedetomidine and midazolam (1 μg kg(−1) + 0.1 mg kg(−1)). All children were anaesthetised with a protocolised anaesthesia technique. The primary end point was the level of sedation when the child was first seen in the operating room 30 minutes after nebulisation. The secondary end points were parental separation and ease of induction, ease of acceptance of IV cannula, mask acceptance, postoperative analgesia, and wake-up behaviour. RESULTS: Studied groups were comparable in demographic data (age, weight, and sex) and duration of anaesthesia. Level of sedation at 30 minutes was significantly greater in the DM group than in the DK group (P  = .013) while the two were comparable in parental separation and ease of induction (P  = .808). Group DK exhibited superior ease of acceptance of IV cannula (P  = .001), mask acceptance score (P  = .001), and postoperative analgesia (P  = .021). Hemodynamic parameters and oxygen saturation remained comparable at all time intervals as also the wake-up behaviour. CONCLUSIONS: The nebulised combination of low-dose ketamine and dexmedetomidine was a superior combination producing acceptable sedation with enhanced ease of IV acceptance, mask acceptance, and postoperative analgesia in children. Turkish Society of Anaesthesiology and Reanimation 2022-10-01 /pmc/articles/PMC9682967/ /pubmed/36301288 http://dx.doi.org/10.5152/TJAR.2022.21298 Text en © Copyright 2022 authors https://creativecommons.org/licenses/by/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Original Article
Dhiman, Tanvi
Verma, Versha
Verma, Ravinder Kumar
Rana, Shelly
Singh, Jai
Badhan, Isha
Dexmedetomidine–Ketamine or Dexmedetomidine–Midazolam Nebulised Drug Combination as a Premedicant in Children: A Randomised Clinical Trial
title Dexmedetomidine–Ketamine or Dexmedetomidine–Midazolam Nebulised Drug Combination as a Premedicant in Children: A Randomised Clinical Trial
title_full Dexmedetomidine–Ketamine or Dexmedetomidine–Midazolam Nebulised Drug Combination as a Premedicant in Children: A Randomised Clinical Trial
title_fullStr Dexmedetomidine–Ketamine or Dexmedetomidine–Midazolam Nebulised Drug Combination as a Premedicant in Children: A Randomised Clinical Trial
title_full_unstemmed Dexmedetomidine–Ketamine or Dexmedetomidine–Midazolam Nebulised Drug Combination as a Premedicant in Children: A Randomised Clinical Trial
title_short Dexmedetomidine–Ketamine or Dexmedetomidine–Midazolam Nebulised Drug Combination as a Premedicant in Children: A Randomised Clinical Trial
title_sort dexmedetomidine–ketamine or dexmedetomidine–midazolam nebulised drug combination as a premedicant in children: a randomised clinical trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682967/
https://www.ncbi.nlm.nih.gov/pubmed/36301288
http://dx.doi.org/10.5152/TJAR.2022.21298
work_keys_str_mv AT dhimantanvi dexmedetomidineketamineordexmedetomidinemidazolamnebuliseddrugcombinationasapremedicantinchildrenarandomisedclinicaltrial
AT vermaversha dexmedetomidineketamineordexmedetomidinemidazolamnebuliseddrugcombinationasapremedicantinchildrenarandomisedclinicaltrial
AT vermaravinderkumar dexmedetomidineketamineordexmedetomidinemidazolamnebuliseddrugcombinationasapremedicantinchildrenarandomisedclinicaltrial
AT ranashelly dexmedetomidineketamineordexmedetomidinemidazolamnebuliseddrugcombinationasapremedicantinchildrenarandomisedclinicaltrial
AT singhjai dexmedetomidineketamineordexmedetomidinemidazolamnebuliseddrugcombinationasapremedicantinchildrenarandomisedclinicaltrial
AT badhanisha dexmedetomidineketamineordexmedetomidinemidazolamnebuliseddrugcombinationasapremedicantinchildrenarandomisedclinicaltrial